洛陽玻璃股份(01108.HK)上半年淨利達1.98億元 同比增長1126.73%
格隆匯8月17日丨洛陽玻璃股份(01108.HK)公佈中期業績,截至2021年6月30日止6個月,公司營業收入為人民幣15.95億元,同比增長66.52%;歸屬於上市公司股東的淨利潤為人民幣1.98億元,同比增長1,126.73%;歸屬於上市公司股東的扣除非經常性損益的淨利潤為人民幣1.86億元,同比增長2,521.22%,基本每股收益為人民幣0.3611元。
公吿稱,報吿期產品銷售量價齊升,收入相應增加。
公司堅持以高質量發展為引領,主動適應行業形勢變化;加快併購整合和項目建設;堅持以管理提升為抓手,補短板、調結構、降成本,強化對標管理,確保生產經營實現了總體平穩、穩中有進。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.